tiprankstipranks
Trending News
More News >

GeneDx price target lowered to $110 from $135 at TD Cowen

TD Cowen lowered the firm’s price target on GeneDx (WGS) to $110 from $135 and keeps a Buy rating on the shares. The firm noted the shares fell after reporting better than expected results and raising guidance. The TAM is largeand barely penetrated, execution has been solid, NICU ramp driving volumes is logical, and price/margins beat and Cowen sees upside.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue